Company News

Bachem Expands Peptide Manufacturing Capacity in Switzerland

2025-01-15
Bachem Expands Peptide Manufacturing Capacity in Switzerland

Bachem announces major expansion of peptide manufacturing facilities in Switzerland, featuring state-of-the-art SPPS and LPPS capabilities to meet growing global API demand.

Bachem Holding AG, a leading peptide manufacturer, announced a major expansion of its Swiss manufacturing facilities to meet rising international demand for peptide APIs. The new facility will feature state-of-the-art solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS) capabilities, enabling the production of complex peptides at greater scale and efficiency. The expansion includes a new site in Sisslerfeld focused on large-scale peptide manufacturing, ensuring continued supply to meet market demands for decades to come. Building K expansion is expected to go live in H2 2025. This strategic investment reinforces Bachem's position as the preferred partner for large-scale commercial peptide manufacturing, with new multi-year supply agreements with pharmaceutical companies developing GLP-1 analogs and other metabolic disease peptide therapeutics.
Read Full Source Article

Hope to become your Partner

Contact us on Telegram for product inquiries, pricing, and orders.

Contact on Telegram
MINSTAR

Shanghai Minstar Chemical Co., Ltd.
RAW API Supplier | Q2 2026 Catalogue.
Shipping from USA and International warehouses.

All products for research use only, not for human or veterinary use, no sales to individuals.

Quick Links

Official Contact

Building 8, No. 1098, Chuansha Road,
Pudong, Shanghai, China

© 2026 Shanghai Minstar Chemical Co., Ltd. All Rights Reserved. | Prices subject to change without notice.